<DOC>
	<DOCNO>NCT00477880</DOCNO>
	<brief_summary>RATIONALE : Monoclonal antibody , cetuximab , block tumor growth different way . Some block ability tumor cell grow spread . Others find tumor cell help kill carry tumor-killing substance . PURPOSE : This clinical trial study well cetuximab work treat patient Ménétrier disease high risk develop stomach cancer .</brief_summary>
	<brief_title>Cetuximab Treating Patients With Ménétrier Disease High Risk Developing Stomach Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Evaluate clinical biochemical parameter response patient Ménétrier disease high risk develop gastric cancer treat cetuximab . OUTLINE : This non-randomized study . Patients receive cetuximab IV day 1 , 8 , 15 , 22 . Treatment repeat every 4 week absence disease progression unacceptable toxicity . Patients complete quality life questionnaire baseline week 4 . PROJECTED ACCRUAL : A total 10 patient accrue study .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Gastritis , Hypertrophic</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm Ménétrier disease Symptomatic disease , include gastrointestinal symptom interfere daily life Patient consider surgery Must fail medical therapy give 6 month No Helicobacter pylori infection PATIENT CHARACTERISTICS : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No NYHA class IIIIV cardiovascular disease No clinically unstable pulmonary disease No chronic disease require ongoing therapy stabilization , include follow : Uncontrolled diabetes mellitus Malignancy Thyroid disease Hypertension Active infection require systemic antibiotic , antiviral , antifungal Uncontrolled seizure disorder Active neurological disease No unstable coagulation disorder ( e.g. , hemorrhagic diatheses active bleed disorder ) require medical management PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>giant hypertrophic gastritis</keyword>
</DOC>